Victory Capital Management Inc. raised its holdings in shares of Clorox Co (NYSE:CLX) by 10.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,475 shares of the company’s stock after purchasing an additional 2,465 shares during the quarter. Victory Capital Management Inc.’s holdings in Clorox were worth $3,789,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the company. Parnassus Investments CA grew its holdings in shares of Clorox by 1.7% during the third quarter. Parnassus Investments CA now owns 4,451,150 shares of the company’s stock worth $587,151,000 after buying an additional 76,236 shares in the last quarter. APG Asset Management N.V. grew its holdings in shares of Clorox by 38.6% during the fourth quarter. APG Asset Management N.V. now owns 1,804,215 shares of the company’s stock worth $223,483,000 after buying an additional 502,300 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Clorox by 0.7% during the third quarter. Bank of New York Mellon Corp now owns 1,062,319 shares of the company’s stock worth $140,129,000 after buying an additional 7,222 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Clorox by 33.9% during the fourth quarter. Acadian Asset Management LLC now owns 1,049,445 shares of the company’s stock worth $156,092,000 after buying an additional 265,892 shares in the last quarter. Finally, Swiss National Bank grew its holdings in shares of Clorox by 1.0% during the third quarter. Swiss National Bank now owns 919,892 shares of the company’s stock worth $121,343,000 after buying an additional 9,300 shares in the last quarter. 73.42% of the stock is owned by institutional investors and hedge funds.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.00% of the company’s stock.
Clorox (NYSE:CLX) last announced its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the company posted $1.14 EPS. The company’s revenue was up .7% compared to the same quarter last year. analysts expect that Clorox Co will post 6.23 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, May 11th. Shareholders of record on Wednesday, April 25th will be given a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, April 24th. This represents a $3.84 dividend on an annualized basis and a yield of 2.92%. This is a boost from Clorox’s previous quarterly dividend of $0.84. Clorox’s dividend payout ratio is presently 55.45%.
A number of research firms have recently issued reports on CLX. BMO Capital Markets set a $147.00 target price on shares of Clorox and gave the stock a “buy” rating in a report on Monday, February 5th. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $147.00 target price for the company in a report on Tuesday, February 6th. Argus lowered shares of Clorox from a “buy” rating to a “hold” rating and dropped their target price for the stock from $150.40 to $127.81 in a report on Thursday, February 8th. Morgan Stanley dropped their target price on shares of Clorox from $140.00 to $133.00 and set an “equal weight” rating for the company in a report on Monday, February 5th. Finally, Bank of America dropped their target price on shares of Clorox from $155.00 to $140.00 and set a “neutral” rating for the company in a report on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the stock. Clorox presently has an average rating of “Hold” and a consensus price target of $132.46.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.